Sign Up For Life Science Leader Magazine

EXECUTIVE INTERVIEWS

Companies To Watch Roundup 2014

The "Companies to Watch" column appears in these pages every month, each time giving a brief but analytical look at a company with its own products in development, relatively little press coverage to date, and a recent milestone accomplished.

More From Executive Interviews

THE CURRENT ISSUE

  • The CDMO Model And Outsourcing Development
    The CDMO Model And Outsourcing Development

    In 2014, the biopharmaceutical industry witnessed more and more contract suppliers take on the CDMO (contract development and manufacturing organization) acronym to identify their ability to assist at the development stage of drug manufacturing. These businesses can provide comprehensive services, from drug development through to manufacturing commercial supply, and are interested in differentiating their abilities from CMOs focused solely on large-scale manufacturing projects.

  • Ask The Board
    Ask The Board

    Q: What innovations are needed to create better diagnostics for personalized medicine, and how can payors support them?

  • What Are The Top BioPharma Trends To Watch In 2015?
    What Are The Top BioPharma Trends To Watch In 2015?

    Prior to the end of 2014, we sent an email to every member of Life Science Leader ’s (LSL’s) editorial advisory board (EAB) listed on p. 8. In addition to thanking them for their service and making sure they were getting value from participating, we sought their insights. Specifically, we asked each to please provide a bulleted list of the top three trends, topics, issues, or people LSL should be covering in 2015. While the responses were as diverse as EAB member backgrounds, some common themes did emerge, starting with globalization.

  • What Kind Of Environment Do You Create As A Leader?
    What Kind Of Environment Do You Create As A Leader?

    A recent client of mine — we’ll call him Eli — was transitioning into a new role in a new company. After several months on the job, establishing and immersing himself in the new culture, he asked me to collect some feedback on his colleagues’ opinions of him.

  • Precision Oncology: Big Data And Analytics Come To Cancer Care
    Precision Oncology: Big Data And Analytics Come To Cancer Care

    Cancer care is creating a new era of precision oncology. Profiling the molecular alterations in a patient’s tumor can identify changes that correlate with likely response or resistance to particular therapies. This type of molecular profiling also can lead to more precise treatment, replacing historical “one-size-fits-all” approaches.

  • Overlooking GMP Biopharm Education/Training Can Cost You – Big Time
    Overlooking GMP Biopharm Education/Training Can Cost You – Big Time

    Today, GMP-compliant manufacturing of biopharmaceutical drugs and vaccines is still only partially automated and not at the level of other manufacturing industries. Critical process steps such as sampling, sterile connection, or column packing are carried out manually by operators, which can negatively impact process reproducibility, product quality, and — in the worst case — even patient safety.

  • Janssen Pharmaceuticals R&D Adopts A Venture Capital Innovation Model
    Janssen Pharmaceuticals R&D Adopts A Venture Capital Innovation Model

    Faced with diminishing returns on R&D investments, large pharmaceutical companies are searching for innovative ways to successfully identify, develop, and market products with financial viability. Yet small discovery companies and biotechs continue to outpace large pharma in the approval of NMEs (new molecular entities).

More Magazine Articles....

LIFE SCIENCE TRAINING INSTITUTE

More From LSTI
Newsletter Signup
Newsletter Signup
Get the latest industry news, insights, and analysis delivered to your inbox.
Join your peers
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

VIEW THE DIGITAL EDITION

 UPCOMING EVENTS

Monitoring Informed Consent (IC): Frequently Asked Questions

February 2, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Regulatory Affairs for Biologics – A Compliance Primer

February 4, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Surviving a FDA GCP Inspection – Preparation Techniques for Success

February 5, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

FDA Guidance on Social Media: Questions Answered and Unanswered

February 10, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Strategic Clinical Project Management: Principles and Practical Applications

February 11, 2015
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
See All Events